. 2022 Jan 19;32(3):288–296. doi: 10.1136/ijgc-2021-002473

Table 2.

Summary of patient and treatment characteristics and treatment outcomes of the included cohort studies. Outcome data are expressed at 5 years, unless indicated differently

Author (year of publication)	Years of inclusion	No of patients	Mono/ multi center	Prospective/ retrospective	Median FU (months)	Age (years)	FIGO stage (n (%))				HT device	HT temp (median °C)	Outcome
Author (year of publication)	Years of inclusion	No of patients	Mono/ multi center	Prospective/ retrospective	Median FU (months)	Age (years)	I	II	III	IV	HT device	HT temp (median °C)	LC/PC	DSS	OS
Franckena (2009)⁴⁷	1996–2005	378	Multi	Retrospective	44	58	13 (3)	160 (42)	163 (43)	42 (11)	Radiative	40.6	53	47	40
Westermann (2012)⁴⁸	1998–2002	68	Multi	Prospective	81	45	3 (4)	42 (62)	21 (31)	2 (3)	Radiative	40.7	NA	58	66
Kroesen (2019)²⁰	2005–2016	227	Mono	Retrospective	52	54	32 (14)	118 (52)	53 (23)	24 (11)	Radiative	40.5	73	60*	40*

*Based on 12 years of follow-up.

DFS, disease free survival; FIGO, International Federation of Gynecology and Obstetrics stage 2008; FU, follow-up; LC, local control; NA, not available; OS, overall survival; PC, pelvic control.